{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-125344","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2025-12-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.981004+00:00","generated_at":"2026-05-16T11:54:07.155637+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Profound Medical closes $6.45M private placement of 921,428 shares at $7.00 each","bullets":["Issued 921,428 common shares at US$7.00 per share to Canadian investors for gross proceeds of ~US$6.45M.","Proceeds to be used for sales and marketing expansion, working capital, R&D, strategic transactions, and general corporate purposes.","Shares subject to four-month-plus-one-day hold period under Canadian securities laws.","Company to file resale registration statement with SEC within four months of closing.","Offering closed on December 30, 2025, under Regulation S exemption from U.S. registration."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-125344","json":"https://secwatch.observer/filing/0001104659-25-125344.json","markdown":"https://secwatch.observer/filing/0001104659-25-125344.md","text":"https://secwatch.observer/filing/0001104659-25-125344.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000110465925125344/0001104659-25-125344-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000110465925125344/tm2534550d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T11:54:07.155637+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ad49fce4352b0921702da8b4be34f8437e191826","claim":"Profound Medical Corp. entered into Subscription Agreement with certain Canadian investors valued at aggregate gross proceeds of $6.45 million (effective 2025-12-30).","evidence_excerpt":"On December 30, 2025, Profound Medical Corp. (the “Company”) entered into a subscription agreement (the “Subscription Agreement”) with certain Canadian investors (the “Investors”) providing for the private placement of an aggregate of 921,428 shares of the Company’s common shares (the “Shares”), at a per share purchase price of $7.00 (the “Offering”) for aggregate gross proceeds of $6.45 million.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628808/000110465925125344/0001104659-25-125344-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain Canadian investors"},{"label":"Value","value":"aggregate gross proceeds of $6.45 million"},{"label":"Effective","value":"2025-12-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}